[Endocrine disruptors and allergy].
Inadera
Hidekuni
H
Department of Public Health, Toyama Medical and Pharmaceutical University. inadera@ms.toyama-mpu.ac.jp
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology; D018932:Chemokine CCL2 / Q000096:biosynthesis / Q000187:drug effects; D004703:Endocrine System / Q000187:drug effects*; D004785:Environmental Pollutants / Q000009:adverse effects*; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology / Q000276:immunology*; D007073:Immunoglobulin E / Q000097:blood; D008297:Male; D051379:Mice; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology; D015262:Xenobiotics / Q000009:adverse effects*
D018932:Chemokine CCL2; D004785:Environmental Pollutants; D004967:Estrogens; D015262:Xenobiotics; D007073:Immunoglobulin E